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Methods: We assessed annual incidence and prevalence using longitudinal data from nationwide
registries on dementia status and demographics on all residents  65 years old in Denmark.
Results: Our population comprised 2 million people, of whom 152,761 were diagnosed with demen-
tia. The age- and sex-adjusted incidence rate increased, on average, by 9% annually from 1996 to
2003, followed by a 2% annual decline, while total prevalence increased during the whole period.
Discussion: This is the first study to report continuous time trends of incidence and prevalence in an
entire national population. The incidence rate has declined steadily since 2003, while the total prev-
alence is still increasing. Future health care planning on prevention and treatment of dementia should
take these findings into account.
 2019 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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In 2015, the World Alzheimer Report estimated that 46.8
million people worldwide were living with dementia and
projected an increase to 131.5 million by 2050 [1]. The
magnitude and potential consequences of the expected in-
crease in prevalence have led to a stronger focus on the po-
tential for prevention and on finding a cure for Alzheimer’s
disease (AD) and other dementia disorders.
The risk of developing dementia is influenced by a combi-
nation of lifestyle and genetic factors. In a recent Lancet Com-
mission article, Livingston et al. presented a model fort: G.W., K.J., A.N., and L.T. reported grants from the
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he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).quantifying the impact of individual factors on overall risk of
dementia [2]. The authors concluded that approximately 35%
of the risk of developing dementia was potentially modifiable,
encompassing mainly midlife and late-life risk factors such as
hypertension, obesity, smoking, physical inactivity, diabetes,
depression, social isolation, and hearing loss [2]. The Finnish
Geriatric Intervention Study to Prevent Cognitive Impairment
and Disability indicated that a multifaceted intervention pro-
gram aimed at at-risk elderly people may prevent cognitive
decline by focusing on cardiovascular risk factors [3]. In
high-income countries, treatment of cardiovascular risk factors
has improved and the focus on healthy lifestyles has increased
during the last three decades [4]. Thus, it is plausible that, with
general improvement in health and better control of risk factors,
prevention of dementia may be possible to some extent.
Recent follow-up studies in large population-based co-
horts indicated a possible decline in the incidence of demen-
tia in the elderly during the past 10-42 years [5–11].imer’s Association. This is an open access article under the CC BY-NC-ND
L. Taudorf et al. / Alzheimer’s & Dementia 15 (2019) 1383-13911384Nevertheless, study results are inconsistent and, in some
studies, the declining incidence was driven mainly by
certain subgroups of either men, women, or specific
subtypes of dementia [5,7,8].
Although population-based cohort studies offer detailed,
systematic data on the individual participants, they have lim-
itations, such as small cohorts, discontinuous data collection
with long follow-up intervals, high dropout rates, recruit-
ment from a small geographical area, and selection bias.
Denmark’s unique national registries enable linkage be-
tween a wide range of registries, including, for example, de-
mographic and continuous health care data at an individual
level for every resident [12]. Consequently, it is possible to
explore time trends in an entire population based on high
quality health care data from the secondary sector. Investi-
gating time trends in incidence and prevalence of dementia
is vital in planning future health care services and, hence,
the ability to provide the best care and treatment for people
with dementia.
The aim of this study was to investigate registry-based
time trends in incidence and prevalence rates of dementia
in an entire national population over a 20-year period. We
hypothesized that the incidence of dementia may have
declined in recent years, despite increasing prevalence.2. Methods
We linked nationwide population data from the Danish
Civil Registration System to information about dementia
status using data from the Danish National Patient Registry,
the Danish Psychiatric Central Research Register, and the
Danish National Prescription Registry [12–15]. Every
individual living permanently in Denmark is given a
unique personal identification number, enabling linkage of
data from Danish registries [13].2.1. Registries and data
The Danish National Patient Registry and the Danish Psy-
chiatric Central Research Register began registering data on
all hospital admissions in 1977 and 1969, respectively, and
in 1995, they began collecting data from emergency depart-
ments and hospital-based outpatient clinics [12,14]. At every
patient contact, date of admission and discharge, and
primary and optional secondary diagnosis have been
registered according to the International Classification of
Diseases, 8th revision (ICD-8) from 1977 to 1993 and the
10th revision (ICD-10) from 1994 [12,14]. ICD-9 was never
implemented in Denmark [12]. The Danish National Patient
Registry has collected information on filled prescription
medication since 1995. Data include date of dispensing,
dose, strength, and the Anatomical Therapeutic Chemical
code (ATC code) [15]. Because of the implementation of
ICD-10 and opening of the Danish Prescription Registry,
the observation period was defined as January 1, 1996 to
December 31, 2015.2.2. Definition of dementia
A diagnosis of dementia was defined as either a registered
dementia diagnosis in the Danish National Patient Registry
or the Danish Psychiatric Central Research Register
(Supplementary Table S1 lists the diagnostic codes), or as
having filled at least one prescription for an anti-dementia
drug (ATC: N06D, see Supplementary Table S2, which lists
ATC codes for pharmaceutical treatment of dementia). Date
of dementia onset was defined as the date of the first demen-
tia diagnosis registered or the date of the first prescription
filled, whichever came first.
2.3. Study population
People were included in the study upon turning 65 years,
or if they were between 65 and 110 years old and registered
as living in Denmark at some point from 1996 to 2015.
Owing to the potential risk of misregistration, people older
than 110 years were censored. The study population will
be referred to as people aged 65 years and older.
2.3.1. Incidence study
Incident cases were defined as people diagnosed with de-
mentia, according to the abovementioned definition, for the
first time within a given calendar year. People diagnosed
with dementia before the age of 65 were excluded because
we wanted to investigate incident cases in people aged
65 years and older. Individuals were censored when they
were diagnosed with dementia, emigrated, were lost to
follow-up, died, turned 110 years old, or at the end of the
study period, whichever came first.
2.3.2. Prevalence study
Prevalent cases were defined as people aged 65 years or
older registered with a dementia diagnosis from 60 years
of age, as a previous study showed that the validity of de-
mentia diagnoses in the Danish registries given before the
age of 60 years is low [16]. The rest of our study population
served as the reference group. Individuals were censored
when they emigrated, were lost to follow-up, died, turned
110 years old, or at the end of the study period, whichever
came first.
2.4. Statistical analysis
Trends in incidence rates were tested with survival anal-
ysis techniques using Poisson regression analysis evaluating
the calendar year as a time-dependent covariate. Incidence
rates were calculated for men and women in strata of five-
year age groups (65-69, 70-74, 75-79, 80-84, and 851).
Trends in prevalence were evaluated as annual period prev-
alence percent by comparing the number of person-years
lived by people with dementia to the total number of
person-years lived in the study population each year. Preva-
lence period percent was calculated for men and women in
strata of five-year age groups (65-69, 70-74, 75-79, 80-84,
Table 1
Demographic data for all Danish residents aged 65 years and older; total number of people living with dementia; and the percentage of people living with
dementia presented for the first and the last year in the 20-year observation period. The distribution is shown for men, women, age groups, median age, and
interquartile range.
1996 2015
All (n) Dementia (n) (%) All (n) Dementia (n) (%)
All 803,334 14,019 1.75 1,055,984 36,129 3.42
Men 332,857 4554 1.37 481,331 13,271 2.76
Women 470,477 9465 2.01 574,653 22,858 3.98
Age (years)
65-69 225,551 838 0.37 353,724 2036 0.58
70-74 208,162 1849 0.89 274,746 4185 1.52
75-79 163,644 2875 1.76 187,236 6492 3.47
80-84 116,090 3693 3.18 122,514 8607 7.03
85-89 63,162 3177 5.03 74,933 8744 11.67
901 26,725 1587 5.94 42,831 6065 14.16
Median age 74.2 82.1 72.9 83.2
IQR 69.5-80.2 76.6-86.8 68.8-79.3 77.5-88.2
Abbreviation: IQR, Interquartile range.
L. Taudorf et al. / Alzheimer’s & Dementia 15 (2019) 1383-1391 138585-89, and 901). Prevalence period percent will be referred
to as prevalence rates. Total incidence was evaluated as the
total number of new dementia cases each year, while total
prevalence was evaluated as point prevalence on January
first.
Supplemental analyses of incidence by birth year were
made to assess a possible birth cohort effect.
The analyses were performed using SAS, version 9.4
(SAS Institute Inc., Cary, NC). This study was approved
by the Danish Data Protection Agency, Statistics Denmark,
and the Danish Health and Medicines Authority.3. Results
Between 1996 and 2015, there were 1,999,375 people
(men: 920,093; women: 1,079,282) aged 65 years and older
living in Denmark. A total of 152,761 people were diag-
nosed with dementia (men: 57,977; women: 94,784)
observed over 16,944,630 person-years (men: 7,415,232;
women: 9,529,398). During the 20-year study period,
170,478 people had been living with a dementia diagnosis
(men: 64,559; women: 105,919).
The population for the prevalence study was followed
over 17,541,315 person-years. Of these, 16,986,832 were
lived without dementia (men: 7,439,899; women:
9,546,933) and 554,483 with dementia (men: 188,936;
women: 365,547).
Table 1 shows the age and sex distribution of the total
elderly population and of people with dementia in 1996
and 2015. As shown, the total elderly population increased
from 803,334 in 1996 to 1,055,984 in 2015, while the me-
dian age decreased from 74.2 years in 1996 to 72.9 years
in 2015. The percentage of people with dementia increased
over the 20-year period for all age groups, and the trend
was most pronounced in the oldest age groups.Fig. 1A and B show time trends in incidence rates in
women and men, respectively. Incidence rates were signifi-
cantly higher in 2015 than in 1996 in all age groups in
both men and women, except for men and women aged
65-69 years. The increase in incidence rates was most domi-
nant in the oldest age groups. However, the increased inci-
dence rates from 1996 to 2015 reflected a steep increase
from 1996 to 2003, followed by stabilization/fluctuation un-
til 2009 and 2010, and then a moderate decline from 2010 to
2015. This time trend was most predominantly observed in
the oldest age groups. When assessing trends in the inci-
dence rate adjusted for age and sex from 1996 to 2003 and
from 2004 to 2015, we found an average annual increase
in incidence rate of 9% from 1996 to 2003. From 2004 to
2015, the incidence rate decreased by 2%, on average, annu-
ally. The total incidence percentage of dementia increased
from 0.58% in 1996 to 0.72% in 2015. The additional anal-
ysis investigating the incidence of dementia by birth year did
not show any clear effect of birth cohort on incidence
(Supplementary Figs. S1-4).
Fig. 2A and B show time trends in prevalence rates (pre-
sented as percent of the total elderly population) in women
and men, respectively. Prevalence rates increased from
1996 to 2015 for both sexes in all age groups. The older
the age group, the higher the prevalence. The prevalence
rates were higher in women than in men aged 75 years and
above. For both men and women, the prevalence rates
have been relatively stable since 2010.
Fig. 3 and Supplementary Figs. S5 and S6 show overall
trends in total incidence and prevalence. The total incidence
increased from 4875 people diagnosed in 1996 to 8017 peo-
ple in 2015. The highest incidence was observed in 2009
(n 5 8832). The prevalence increased from 14,019 people
in 1996 to 36,129 people in 2015. The prevalence increased
steadily over the total period, although with a lower rate of
increase in most recent years.
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Fig. 1. (A) Time trend of incidence rates of dementia in Danish women from 1996 to 2015. Error bars represent 95% confidence intervals. (B) Time trends of
incidence rates of dementia in Danish men from 1996 to 2015. Error bars represent 95% confidence intervals.
L. Taudorf et al. / Alzheimer’s & Dementia 15 (2019) 1383-139113864. Discussion
To our knowledge, this is the first complete national pop-
ulation study based on routine health care data to confirm
trends in declining incidence of dementia that have previ-
ously been described in population-based research studies.
For men and women in all age groups, incidence rates
reached their peak values from 2003 to 2010, followed by
a decline. Adjusted for age and sex, the incidence rate of de-
mentia in the total population increased annually by 9%, on
average, until 2003, followed by a 2% annual decline. The
prevalence rates increased for men and women in all age
groups during thewhole period from 1996 to 2015, most pre-
dominantly in the oldest age groups. Thus, while incidencerates stabilized around 2003 and have declined since 2010,
the total prevalence of dementia is still increasing.
Several population-based studies have compared inci-
dence and prevalence in two, or more, time intervals. Nine
studies in high-income countries have investigated trends
in dementia incidence using population-based cohort study
designs: The Rotterdam Study: 1990 and 2000 (The
Netherlands) [6]; The Cognitive Function and Aging Studies
(CFAS): 1990-1994 and 2008-2011 (UK) [8]; The English
Longitudinal Study of Aging: 2002-2013 (UK) [11]; The
Indianapolis-Ibadan Dementia Project (IIDP): 1992 and
2001 (USA) [9]; The Framingham Heart Study: 1977-
1983, 1986-1991, 1992-1998, and 2004-2008 (USA) [5];
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Fig. 2. (A) Time trends of dementia prevalence rates in Danish women from 1996 to 2015. (B) Time trends of dementia prevalence rates in Danish men from
1996 to 2015.
0
5000
10000
15000
20000
25000
30000
35000
40000
Nu
m
be
r o
f p
eo
pl
e
Year
Prevalence
Incidence
Fig. 3. Time trends of total incidence and prevalence of dementia in
Denmark from 1996 to 2015.
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2000, 2001-2003, 2004-2006, 2007-2009, and 2010-2012
(USA) [17]; The Einstein Aging Study: 1993-2015 (USA)
[10]; The Bordeaux Study: 1988-1989 and 1999-2000
(France) [7]; and The Hisayama Study: 1998 and 2012
(Japan) [18]. A recent meta-analysis included the Rotterdam
Study, the IIDP, the Bordeaux Study, the CFAS, and the Hi-
sayama Study [19]. Overall, the meta-analysis concluded
that the results indicated a stabilizing trend in incidence of
dementia rather than a decline [19]. It also found that the
risk of bias for domains of external validity was high for
all study populations, except for the UK and Japanese
studies, indicating that the study populations could be unrep-
resentative of their national populations [19]. Furthermore,
L. Taudorf et al. / Alzheimer’s & Dementia 15 (2019) 1383-13911388they concluded that there was a risk of minimal nonresponse
bias in the Rotterdam Study, the IIDP, the Bordeaux Study,
and the Framingham Heart Study [19]. The quantitative syn-
thesis suggested a nonsignificant decline of incidence of de-
mentia; however, the heterogeneity between studies was
high [19].
The declining incidence suggested in most of these
studies may be related to changes over time in the risk factor
profile. Thus, the Bordeaux Study found the later cohort was
better educated, had a lower stroke prevalence, and used
more antihypertensive and lipid-lowering drugs [7]. When
adjusting for cardiovascular status and educational level,
however, the association only explained some of the
decrease seen in women [7]. The Framingham Heart Study
found a decreasing effect of cardiovascular events and an
increased effect of treatment with antihypertensive drugs
on the risk of developing dementia in the later cohorts,
although this benefit seemed to be more noticeable in people
with at least a high school diploma [5]. When evaluating de-
mentia subtypes, the Framingham Heart Study found a sig-
nificant trend in decline only for vascular dementia, not
AD, whereas the IIDP noted a decline in all-cause dementia
and in AD [5,9]. The Hisayama Study reported a significant
increase in incidence of AD, while incidence of vascular
dementia remained stable over time [18]. This increase
may partly reflect a difference in risk factor profiles and
the ethnicity in high-income countries in the Western world
and in East Asia.
Time trends in the incidence of dementia have also been
reported in a few studies based on registry data. A German
study evaluated incidence rates based on samples from
health insurance data in 2006/07 and 2009/10 and reported
a significant decline between the two time points [20].
Two Canadian studies assessed continuous time trends of
incidence rates in the provinces of Saskatchewan (2005-
2013) and Ontario (2002-2013), respectively, based on
data from administrative health databases [21,22]. The
Saskatchewan study reported a significant decline in
incidence rates from 2005 to 2013 [21]. Findings from On-
tario had a pattern similar to our study, with fluctuations
from 2002 to 2008 followed by a decline, but the overall
trend in declining incidence was only significant in women
[22]. A Dutch registry-based study using data from primary
care only reported an annual growth in incidence of 2.1%
from 1992 to 2014 [23]. Registry-based data from hospital-
ized inpatients in Sweden on incidence rates of dementia
from 1987 to 2016 demonstrated an increase until 2011, fol-
lowed by a decline [24]. Thus, although there is a lack of
consistency among results from registry-based studies,
many have indicated stabilizing or declining trends in inci-
dence rates of dementia during recent years, while some
only observe these trends to be limited to subgroups and
one study reported increasing incidence.
In our study, we also assessed time trends in prevalence
rates. To sum up findings from ten population-based studies
investigating time trends in the prevalence rates of dementia,the IIDP, a Spanish study, and three Swedish studies
observed a stable prevalence, whereas the CFAS and an
American study found a declining prevalence and the Hi-
sayama Study found an increasing prevalence [18,25–31].
The Chicago Health And Aging Project found substantial
variation over time but no secular trend from 1994 to 2012
[17]. Using two different analytical approaches, the
Bordeaux study described trends moving in opposite direc-
tions [32]. Most studies investigating prevalence of dementia
reported trends in declining or stabilizing prevalence, while
our study observed trends similar to the Hisayama Study,
with increasing prevalence in both sexes and all ages during
the 20 years.
Our study demonstrates the power of access to continuous
data for assessing time trends as compared with using a few
discrete time points. Had we only compared incidence rates
in 1996 and 2015, the decline since 2009 would have been
missed. Both the initial increase and later decline in demen-
tia incidence rates should be interpreted in the context of
increased public awareness of dementia. In Denmark, the
first memory clinic was established in 1995 and the first
pharmaceutical drug against AD was launched in 1997.
These events have potentially contributed to an increase in
public awareness, and we believe that the marked increase
in incidence from 1996 to 2003 reflects an increased diag-
nostic rate, rather than an actual increase in incidence of de-
mentia. Likewise, there is a possibility that the later decline
could be partly related to a higher precision in diagnosis re-
sulting in a more restrictive use of the diagnosis of dementia.
Thus, when interpreting possible causes for the stabiliza-
tion and later decline in incidence, one hypothesis relates to
improvement in health and another to improved precision in
diagnosing dementia.
First, during the last decades, we have experienced a
marked improvement in living conditions and health in
Western high-income countries. We believe that the general
improvement in health, including better control and treat-
ment of risk factors, may prevent vascular cognitive impair-
ment and may contribute to the observed decline in
incidence of dementia in recent years.
In the Framingham Heart Study, the declining incidence
was only significant for vascular dementia, and not AD
[5]. The Hisayama Study reported stabilization in the inci-
dence of vascular dementia whereas AD increased [18]. Re-
sults from magnetic resonance imaging scans performed in
the Rotterdam Study showed that people in the 2000 cohort
had lesser brain atrophy and fewer white matter lesions than
those in the 1990 cohort [6]. Thus, the decline in incidence
rates reported inWestern high-income countries may mainly
represent vascular dementia.
Our analysis of dementia incidence by birth year did not
demonstrate any effect of birth cohort on incidence.
Second, even though the diagnostic criteria for demen-
tia have not changed within our study period, there have
been improvements over time regarding the application
of neuroimaging and biomarkers for neurodegenerative
L. Taudorf et al. / Alzheimer’s & Dementia 15 (2019) 1383-1391 1389disorders. Consequently, the precision in diagnosis may
have improved, especially when diagnosing subtypes
of dementia. We cannot exclude the fact that this may
have led to a more restrictive use of the dementia (syn-
drome) diagnosis during this period contributing to a
change in diagnostic rate over time and an apparent
decline in incidence.
Even though incidence rates are declining, our study
shows that the number of people living with a registered de-
mentia diagnosis in Denmark (prevalence) is still increasing.
There are two possible explanations for this apparent
paradox. First, the number of elderly people is increasing
because of increasing life expectancy and large birth cohorts
from the 1940s and 1950s having reached the elderly popu-
lation. As the risk of dementia increases with age, we expect
that the larger elderly population will lead to an increasing
number of people living with dementia over the next de-
cades. The large birth cohorts from the 1940s also explain
the fact that the median age of our total elderly population
declined from 74.2 years to 72.9 years from 1996 to 2015
[33]. Second, people may live for a longer time registered
with dementia because of either earlier diagnosis or decline
in mortality. If our study population was registered with de-
mentia at an earlier age later in our study period, this may
have led to an increased amount of time lived with a diag-
nosis. However, the median age of incidence of dementia
was 82.4 years in 1996 and 82.3 years in 2015. Hence, we
do not believe this explanation to be very likely. As life ex-
pectancy is increasing in the general population, there is a
possibility that individuals diagnosed with dementia live
for a longer time with their diagnosis than previously.
Population-based studies from Stockholm, Rotterdam, and
Hisayama have reported declining mortality over time in
people with dementia [6,18,29]. Thus, we believe it to be
possible that individuals with dementia live longer after
being diagnosed, which contributes to the continued
increase in prevalence.4.1. Limitations of the study
This study was based on registered diagnoses from sec-
ondary health care and prescription data identifying 36,129
people living with dementia aged 65 years or more in
2015. Based on extrapolation from European population-
based studies, it is estimated that approximately 87,000 peo-
ple in Denmark aged 60 years or more are living with de-
mentia, likely leaving a large proportion of undiagnosed
cases of dementia [34]. Thus, as in many other countries,
the diagnostic rate may be relatively low. Our study is based
on national health care data from the secondary health sector
and the Danish National Prescription Registry. Thus, our
data reflect diagnoses established in routine medical care
and do not include information on clinical manifestations,
the level of cognitive decline, or diagnostic workup leading
to the diagnosis.National clinical and evidence-based guidelines have
been available in Denmark since 1998, and ICD-10 criteria
were applied for the (syndrome) diagnosis of dementia
throughout the entire period. Brief cognitive testing was rec-
ommended to support a diagnosis of dementia in all recom-
mendations. Our registry-based data do not inform us to
which extent these recommendations were followed when
physicians were making the diagnosis. However, in a previ-
ous study, we evaluated the quality of the registered cases of
dementia in the Danish health care registries and found that
the diagnoses of dementia were justified in 85.8% of the
cases in elderly people [35]. Unfortunately, as a large pro-
portion of the patients were registered with a diagnosis of
“unspecific dementia,” our registry-based data are not suffi-
cient for clarifying the etiology of dementia.
4.1.1. Strengths of the study
Government-funded, universal health care, combined
with unique personal identification numbers, provides an
excellent setting for epidemiological studies. Our study
was based on data using an entire population as the cohort,
which means it is large, has no dropouts, and represents
trends in an entire nation. Data in the Danish registries are
continuously updated and data on follow-up are, for all prac-
tical purposes, complete and registered continuously in all
calendar years.
This study assessed national trends in incidence and prev-
alence in Denmark, and we assume that these trends can be
generalizable to other Western high-income countries that
have similar access to diagnostic evaluation and support.5. Conclusions
In conclusion, our study shows that incidence rates of de-
mentia have declined since 2010. The total incidence of de-
mentia has also declined, while the total prevalence is still
increasing, albeit less rapidly in recent years. When planning
future health care services, it is crucial to take the increasing
number of people living with a dementia diagnosis into ac-
count. In future models for estimating projections of preva-
lence and incidence, the fluctuations in incidence rates and
prevalence percentage over time should be considered. The
decline in total incidence and incidence rates of dementia
leads to a cautious optimism that with better health and man-
agement of risk factors, it may be possible to lower the risk
of dementia. However, previous studies imply that this effect
may be limited to vascular dementia, highlighting the need
for better prevention and treatment of AD and other neuro-
degenerative dementias.Acknowledgments
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1. Systematic review: The authors reviewed the litera-
ture using a PubMed search. Even though there was
evidence of declining or stabilizing incidence of de-
mentia in Western high-income countries, the num-
ber of studies was small and the heterogeneity of
findings was high.
2. Interpretation: Studying an entire national popula-
tion based on high quality routine health care data
from the secondary sector, we observed that the
age- and sex-adjusted incidence rate increased, on
average by 9% annually from 1996 to 2003, followed
by a 2% annual decline from 2004 to 2015. While the
total incidence and incidence rates declined, the total
prevalence was still increasing.
3. Future directions: Future healthcare planning on pre-
vention and management of dementia should take
these findings into account. More studies are needed
to clarify whether the decline in incidence of demen-
tia is limited to vascular dementia. This would
emphasize the great need for targeted treatment for
neurodegenerative dementias.References
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